Macromolecular drug conjugates II: chemical and enzymatic hydrolysis kinetics of the secondary 5-fluorouracil-1-acetic acid/β-cyclodextrin conjugate

被引:1
作者
Luo, Sheng Xia [1 ]
Zhang, Rui Xia [1 ]
Huang, Qing [1 ,2 ]
Xu, Li Sheng [1 ]
Wang, Zhi Zhong [1 ,2 ]
机构
[1] Ningxia Med Univ, Sch Pharm, Yinchuan 750004, Peoples R China
[2] Minist Educ, Key Lab Hui Ethn Med Modernizat, Yinchuan 750004, Peoples R China
关键词
Cyclodextrin; Conjugate; Hydrolysis; Kinetics; alpha-Amylase; Carboxyl esterase; COLON-SPECIFIC DELIVERY; SYSTEMS; DESIGN; PRODRUGS;
D O I
10.1007/s10847-016-0639-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The chemical and enzymatic hydrolysis of the secondary 5-fluorouracil-1-acetic acid/beta-cyclodextrin conjugate were evaluated for potential application as a colon-targeted prodrug. In aqueous buffer solutions at a pH of 1-10, the pH-rate profile for hydrolysis of the conjugate was interpreted in terms of spontaneous or water-catalyzed, and specific base-catalyzed reactions. In the solutions of alpha-amylase, the conjugate was degraded to 5-fluorouracil-1-acetic acid/small saccharide conjugates. In the solutions of carboxyl esterase, the conjugate was gradually hydrolyzed to 5-fluorouracil-1-acetic acid at the similar rate as that in the absence of the carboxyl esterase. 5-Fluorouracil-1-acetic acid was rapidly released when the conjugate was hydrolyzed firstly by alpha-amylase and secondly by carboxyl esterase. On the other hand, the rate of hydrolysis of the conjugate was accelerated significantly by the colonic fluids of rats. It is important to note that the secondary conjugate released the parent drugs more slowly than the primary one.
引用
收藏
页码:167 / 171
页数:5
相关论文
共 18 条
  • [1] Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches
    Amidon, Seth
    Brown, Jack E.
    Dave, Vivek S.
    [J]. AAPS PHARMSCITECH, 2015, 16 (04): : 731 - 741
  • [2] [Anonymous], P ICOCN
  • [3] Biomimetic reactions catalyzed by cyclodextrins and their derivatives
    Breslow, R
    Dong, SD
    [J]. CHEMICAL REVIEWS, 1998, 98 (05) : 1997 - 2011
  • [4] Review: A History of Cyclodextrins
    Crini, Gregorio
    [J]. CHEMICAL REVIEWS, 2014, 114 (21) : 10940 - 10975
  • [5] Modern Prodrug Design for Targeted Oral Drug Delivery
    Dahan, Arik
    Zimmermann, Ellen M.
    Ben-Shabat, Shimon
    [J]. MOLECULES, 2014, 19 (10): : 16489 - 16505
  • [6] Microbial α-amylases:: a biotechnological perspective
    Gupta, R
    Gigras, P
    Mohapatra, H
    Goswami, VK
    Chauhan, B
    [J]. PROCESS BIOCHEMISTRY, 2003, 38 (11) : 1599 - 1616
  • [7] Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue
    Hua, Susan
    Marks, Ellen
    Schneider, Jennifer J.
    Keely, Simon
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (05) : 1117 - 1132
  • [8] What should be considered on design of a colon-specific prodrug?
    Jung, Yunjin
    Kim, Young Mi
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (02) : 245 - 258
  • [9] PRODRUGS AS DRUG DELIVERY SYSTEMS .107. SYNTHESIS AND CHEMICAL AND ENZYMATIC-HYDROLYSIS KINETICS OF VARIOUS MONOESTER AND DIESTER PRODRUGS OF N-ACETYLCYSTEINE
    KAHNS, AH
    BUNDGAARD, H
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 62 (2-3) : 193 - 205
  • [10] Cyclodextrin conjugate-based controlled release system: repeated- and prolonged-releases of ketoprofen after oral administration in rats
    Kamada, M
    Hirayama, F
    Udo, K
    Yano, H
    Arima, H
    Uekama, K
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 82 (2-3) : 407 - 416